Prognostic significance of subclassification of pT2 gastric cancer: A retrospective study of 847 patients

Surgical Oncology

Volumn 17, Issue 4, 2008, Pages 317-322

  Lu, Yang ^a   Liu, Caigang ^a   Zhang, Ruishan ^a   Li, Hua ^a   Lu, Ping ^a   Jin, Feng ^a   Xu, Huimian ^a   Wang, Shubao ^a   Chen, Junqing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Lymph node metastasis; Prognosis; T category

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; DISEASE FREE SURVIVAL; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; STOMACH CANCER; TUMOR LOCALIZATION;

CHINA; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 53049085374     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2008.05.005     Document Type: Review

References (25)

1. Shimoyama S., Seto Y., Yasuda H., Mafune K., and Kaminishi M. Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: date from a quarter-century of experience in a single institution. World J Surg 29 (2005) 58-65
2. Lindsey H. Preoperative chemoradiotherapy shows promise in gastric cancer. Lancet Oncol 5 (2004) 519
3. Takagane A., Terashima M., Abe K., Araya M., Irinoda T., Yonezawa H., et al. Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer. Gastric Cancer 2 (1999) 122-128
4. Ohtsu A., Yoshida S., and Sajio N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol 24 (2006) 2188-2196
5. Adchi Y., Shiraishi N., and Kitano S. Modern treatment of early gastric cancer: review of the Japanese experience. Dig Surg 19 (2002) 333-339
6. Sarela A.I., Turnbull A.D., Coit D.G., Klimstra D., Brennan M.F., and Karpeh M.S. Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma. Ann Surg Oncol 10 (2003) 783-791
7. Kunisaki C., Shimada H., Nomura M., Matsuda G., Otsuda Y., Ono H., et al. Distribution of lymph node metastasis in gastric carcinoma. Hepatogastroenterology 53 (2006) 468-472
8. Potrc S., Gadiijev E., Hajdinjak T., and Kavalar R. Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer. Hepatogastroenterology 54 (2007) 308-314
9. International Union Against Cancer. In: Sobin L.H., and Wittekind C.H. (Eds). TNM classification of malignant tumors. 5th ed. (1997), Wiley, New York
10. Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.G., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York
11. Fotia G., Marrelli D., De Stefano A., Pinto E., and Roviello F. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer. Eur J Surg Oncol 30 (2004) 930-934
12. Yokota T., Kunii Y., Teshima S., Yamada Y., Saito T., Kikuchi S., et al. Gastric cancer with invasion limited to the muscularis propria. Int Surg 84 (1999) 7-12
13. Otsuji E., Kuriu Y., Ichikawa D., Okamoto K., Hagiwara A., and Yamagishi H. Characteristics of gastric carcinoma invading the muscularis propria. J Surg Oncol 92 (2005) 104-108
14. Park D.J., Kong S.H., Lee H.J., Kim W.H., Yang H.K., Lee K.U., et al. Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs PT2b) and lymph node status (pN). Surgery 141 (2007) 757-763
15. Sasaki T. In regard to gastric cancer treatment guidelines - a revised edition. Gan To Kagaku Ryoho 31 (2004) 1947-1951
16. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English ed. Gastric Cancer 1 (1998) 10-24
17. Teramoto K., Tada M., Tamoto E., Abe M., Kawakami A., Komuro K., et al. Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling. J Surg Res 124 (2005) 225-236
18. Yamamoto H., Perez-Piteira J., Yoshida T., Terada M., Itoh F., Imai K., et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 116 (1999) 1348-1357
19. Danielson H., Kokkola A., Kiviluoto T., Siren J., Louhimo J., Kivilaakso E., et al. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer. Scand J Surg 96 (2007) 35-40
20. Luebke T., Baldus S.E., Grass G., Bollschweiler E., Thiele J., Dienes H.P., et al. Histological grading in gastric cancer by Ming classification: correlation with histopathological subtype, metastasis, and prognosis. World J Surg 29 (2005) 1422-1427 1428
21. Nakamura K., Ogoshi K., and Makuuchi H. Did the histologic diversity of the primary tumor affect the patients outcome in gastric cancer?. Int Surg 91 (2006) 308-315
22. Komatsu S., Ichikawa D., Kurioka H., Kan K., Shioaki Y., Ueshima Y., et al. Prognostic and clinical evaluation of patients with T2 gastric cancer. Hepatogastroenterology 52 (2005) 965-968
23. Piso P., Werner U., Lang H., Mirena P., and Klempnauer J. Proximal versus distal gastric carcinoma-what are the differences?. Ann Surg Oncol 7 (2000) 520-525
24. Isozaki H., Fujii K., Nomura E., Mabuchi H., Nishiguchi K., Hara H., et al. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma). Hepatogastroenterology 46 (1999) 2669-2672
25. Okuno K., Shigeoka H., Tanaka A., Hirai N., Matsumara E., and Yasutomi M. Clinicopathological evaluation of T2-gastric cancer among age groups. Hepatogastroenterology 47 (2000) 1180-1182